Specific protein-protein interactions are central to many cellular functions. Detection of these interactions has generally been by co-immunoprecipitation analyses. These methods have drawbacks deriving from the nature of this technique, including the difficulty of cloning gene sequences for newly detected proteins. A yeast-based genetic system to study protein interactions has been described, which is applicable to proteins from any organism. This system detects the in vivo interaction of two hybrid proteins using yeast plasmids that encode chimeric genes. This protein interaction reconstitutes a yeast transcriptional activator (GAL4) function resulting in activation of a reporter gene visualized as color output. The Phase I aims are to evaluate the system's sensitivity to detect protein interaction of different affinities using the p53SV40 T antigen interaction. Previously characterized mutations will be introduced into the SV40 T antigen, analyzed with this system and compared to published co-immunoprecipitation results. The Phase II objective is to extend this method to widespread use by commercializing kits for identification of novel interactions between any protein under study and those encoded by a cDNA/random genomic library. The discovery of such interactions is critical to the understanding of diseases resulting from abnormalities in either signal transduction or cellular organization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI031729-01
Application #
3489501
Study Section
Special Emphasis Panel (SSS (B1))
Project Start
1991-09-15
Project End
1992-03-14
Budget Start
1991-09-15
Budget End
1992-03-14
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Osi Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Uniondale
State
NY
Country
United States
Zip Code
11553